LEMAITRE VASCULAR INC — Director's Dealing 2025

Mar 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-03-27

Reporting Person: SHADAN MARTHA (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-27	Dividend Equivalent Rights	$	A	0.4803	Acquired		Common Stock (0.4803)	Direct
2025-03-27	Dividend Equivalent Rights	$	A	0.4803	Acquired		Common Stock (0.4803)	Direct
2025-03-27	Dividend Equivalent Rights	$	A	0.8214	Acquired		Common Stock (0.8214)	Direct
2025-03-27	Dividend Equivalent Rights	$	A	0.9838	Acquired		Common Stock (0.9838)	Direct
2025-03-27	Dividend Equivalent Rights	$	A	1.001	Acquired		Common Stock (1.001)	Direct

Footnotes

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/24 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.